遠望谷(002161.SZ)累計減持思維列控股票68.78萬股 減持計劃已實施完畢
格隆匯11月18日丨遠望谷(002161.SZ)公佈,經公司財務部門測算,此次減持思維列控股票68.7822萬股,公司預計可獲得投資收益(税前)約2,713.33萬元,將對公司2019年度經營業績產生積極影響。此次減持所獲得具體收益金額,以公司披露的《2019年年度報告》中相關財務數據為準。截至公告披露日,此次減持計劃已實施完畢。
此次減持計劃的實施,有利於提升公司資產的整體運用效率,改善公司財務狀況和業績表現,有利於加強公司綜合競爭力,為公司主營業務發展提供堅實的支撐,從而實現股東利益最大化。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.